Ropes & Gray represented Asimov in a strategic collaboration with Lonza to advance lentiviral vector (LVV) manufacturing for emerging in vivo applications. The deal was announced on October 2, 2026.
Asimov is building an AI-native synthetic biology platform to advance therapeutic development. The company is backed by Andreessen Horowitz, CPP Investments, Horizons Ventures, and Fidelity Management & Research Company.
The Ropes & Gray team was led by life sciences partner Rajarshi Banerjee and intellectual property transactions associate Zoe Dettelbach.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.